Pharmarise HoldingsPharmarise Holdings Corporation2796東証スタンダードサービス業FY ending May 2026, consolidated, J-GAAP
Revenue by business segment, and the profit each one keeps.
Geographic revenue reported in annual filings
No geographic revenue breakdown was disclosed.
※ Segment figures include inter-segment sales and do not sum to the company total
X-axis: segment revenue CAGR. Y-axis: latest operating margin. Bubble size: revenue.
Bubble size represents latest revenue. Segments without a CAGR are placed at the left edge; their horizontal position is not a growth value. Color indicates positive or negative margin.
| Segment | Revenue CAGR | FY ending May 2022 | FY ending May 2023 | FY ending May 2024 | FY ending May 2025 | FY ending May 2026 |
|---|---|---|---|---|---|---|
| Dispensing pharmacy | +6.9%5y | 42,0024.1% | 42,3274.0% | 44,1782.5% | 52,6251.1% | 59,3312.3% |
| Cosmetic,drug and convenience store | +0.2%5y | 7,598-2.0% | 7,771-2.6% | 8,283-0.6% | 8,696-0.5% | 8,042-1.0% |
| Custody of medical documents | +0.8%5y | 69915.3% | 64612.5% | 66413.7% | 6098.4% | 64715.5% |
| Medical mall | +0.6%5y | 50313.3% | 50517.8% | 50622.3% | 51120.2% | 50517.2% |
| Other | +6.6%5y | 8049.8% | 7794.6% | 834-0.6% | 1,064-4.9% | 986-11.5% |
Top: revenue. Bottom: operating margin.
EDINET (FSA Japan)
有価証券報告書-第40期(2025/06/01-2026/05/31)
EDINET (FSA Japan)
有価証券報告書-第39期(2024/06/01-2025/05/31)
EDINET (FSA Japan)
有価証券報告書-第38期(2023/06/01-2024/05/31)
EDINET (FSA Japan)
有価証券報告書-第37期(2022/06/01-2023/05/31)
EDINET (FSA Japan)
有価証券報告書-第36期(令和3年6月1日-令和4年5月31日)
EDINET (FSA Japan)
有価証券報告書-第35期(令和2年6月1日-令和3年5月31日)
Extracted from XBRL: 51 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.